Tissue Engineering Unit CRG

Tissue Engineering Unit CRG is a leading biotechnology research entity dedicated to advancing the frontiers of stem cell biology, stem cell differentiation, organoid formation, and induced pluripotent stem cells (iPSCs). Since its establishment in 2016, Tissue Engineering Unit CRG has been committed to providing cutting-edge technologies to researchers within CRG, PRBB, and the broader scientific community.

Tissue Engineering Unit CRG continuously integrates emerging technologies to enhance its capabilities and support innovative research initiatives. Working in close collaboration with the Biomolecular Screening & Protein Technologies Unit at CRG, Tissue Engineering Unit CRG offers CRISPR/Cas9 genome editing technology services, further solidifying its role as a pivotal resource for biotechnology advancements.

Tissue Engineering Unit CRG is poised for continued growth and innovation, driving progress in regenerative medicine and biotechnology. We invite the manager of Tissue Engineering Unit CRG to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and impact.